Malaysia’s leading pharmaceutical company, Duopharma Biotech Berhad (“Duopharma Biotech”) through its wholly-owned subsidiary, Duopharma ...
The advanced and FDA-cleared Magstim Horizon 3.0 transcranial magnetic stimulation (TMS) system is now UKCA registered and available for sale in the UK, pr...
The DENEX system is an innovative medical device that treats hypertension using minimally invasive renal denervation technology. Electrodes are inserted in...
Validation is a required component of medical device quality assurance. But device manufactures new to CMMs find it challenging to validate the software an...
SciMed offers life science products and services, including ultra-low temperature freezers and CO2 incubators, in Southeast Asia, India, and Oceania. Since...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the worldwide commercial launch of a new automated i...
Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life fo...
The newly introduced ZEISS Volutome is an in-chamber ultramicrotome for ZEISS field emission scanning electron microscopes (FE-SEM). It is designed to imag...
New silicon dielectrics processed via low temperature Plasma Enhanced – Atomic Layer Deposition (ALD) technology enables flexible OLEDs in superior...
With around 5,000 global manufacturers spanning the healthcare supply chain, the CMEF organized by Reed Sinopharm Exhibitions is unparalleled in its scale,...
Working with an inventive medical professional with years of experience applying tattoos to patients to prepare them for radiation therapy treatment, Bioni...
The EVAQ Trial enrolled 121 patients at 17 centers globally. Data from the study will be used as part of an application to the U.S. Food and Drug Administr...
NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has received a ...
The milestone marks the final implantation of the 539th patient enrolled in the prospective, multicenter, randomized, masked, controlled IDE clinical study...
© 2024 Biopharma Boardroom. All Rights Reserved.
